168 filings
Page 7 of 9
8-K
b9kug
12 Feb 14
Public Offering of Common Stock
12:00am
8-K
1gbd8j2 750d8gm
10 Feb 14
Ironwood Pharmaceuticals Announces Proposed Public
12:00am
8-K
a9e2c6k zfw3n
21 Jan 14
Fourth Quarter 2013 Investor Update
12:00am
8-K
j4t 4w7y6
8 Jan 14
Cost Associated with Exit or Disposal Activities
12:00am
8-K
mi1x1t3513hssb1ks mv
26 Nov 13
Entry into a Material Definitive Agreement
12:00am
8-K
k4o45qchi1nb
22 Oct 13
Third Quarter 2013 Investor Update
12:00am
8-K
iocymzc3goos1gmf1l76
23 Jul 13
Second Quarter 2013 Investor Update
12:00am
8-K
4eicxly2cx7v
12 Jun 13
Entry into a Material Definitive Agreement
12:00am
8-K
naa3xw hfpi0
5 Jun 13
Submission of Matters to a Vote of Security Holders
12:00am
8-K
7m140wd5
24 May 13
Public Offering of Common Stock
12:00am
8-K
2d826ns9cfuk9
20 May 13
Ironwood Pharmaceuticals Announces Proposed Public
12:00am
8-K
wc00eus
23 Apr 13
First Quarter 2013 Investor Update
12:00am
8-K
4ajxg0y
5 Mar 13
Ironwood Pharmaceuticals Appoints Edward Owens
12:00am
8-K
bhme mq8q3
15 Jan 13
Fourth Quarter 2012 Investor Update
12:00am
8-K
j56w7
8 Jan 13
Ironwood Completes $175 Million Offering
12:00am
8-K
1f7 eb64szw
31 Oct 12
Entry into a Material Definitive Agreement
12:00am
8-K
gunga4detkb5r
29 Oct 12
Ironwood and Astrazeneca Announce Linaclotide Collaboration for China
12:00am
8-K
r3qlbhebtwcis4qp
16 Oct 12
Third Quarter 2012 Investor Update
12:00am
8-K
vvyuadbemsb
31 Aug 12
Other Events
12:00am
8-K
455gnutxs8atx5s6swl9
18 Jul 12
Second Quarter 2012 Investor Update
12:00am